High-dimensional immune profiling and antigen-specific T cell identification has become indispensable for a comprehensive understanding of the immune response to cancer, infectious- and autoimmune diseases. It has the potential to identify biomarkers and guide the development of therapeutic intervention strategies and vaccines. Cytographer®, ImmunoScape’s cloud-based bioinformatics platform enables advanced analytics on multi-parametric mass- (CyTOF®) and flow cytometry data to generate meaningful interpretations and enhance the potential value derived from clinical trials and other key studies.
Recent Posts
- Nextgen TCR therapies can improve diagnosis and treatment regimens
- Meet us at the 41st Annual JPM Healthcare Conference
- ImmunoScape To Present at the 7th Annual CAR-TCR Summit
- ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-cell Receptors
- Visit us at the 7th Annual CAR-TCR Summit
Archives
- January 2023
- December 2022
- September 2022
- August 2022
- June 2022
- May 2022
- March 2022
- February 2022
- September 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- April 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- June 2018
- May 2018
- April 2018
- February 2018
- November 2017
- October 2017
- September 2017
- July 2017
- May 2017
- April 2017
- March 2017
- January 2017
- August 2016
- July 2016
- April 2016
- January 2016
- June 2015
- October 2014
- January 2014
- June 2013
- January 2012
- July 2011
- June 2009
Recent Comments